Results 41 to 50 of about 2,749,571 (347)

MS0621, a novel small-molecule modulator of Ewing sarcoma chromatin accessibility, interacts with an RNA-associated macromolecular complex and influences RNA splicing

open access: yesFrontiers in Oncology, 2023
Ewing sarcoma is a cancer of children and young adults characterized by the critical translocation-associated fusion oncoprotein EWSR1::FLI1. EWSR1::FLI1 targets characteristic genetic loci where it mediates aberrant chromatin and the establishment of de
Tamara Vital   +31 more
doaj   +1 more source

Maltose-binding protein enhances secretion of recombinant human granzyme B accompanied by in vivo processing of a precursor MBP fusion protein [PDF]

open access: yes, 2010
Background: The apoptosis-inducing serine protease granzyme B (GrB) is an important factor contributing to lysis of target cells by cytotoxic lymphocytes.
Wels, Winfried   +9 more
core   +1 more source

Myeloproliferative neoplasms and the JAK/STAT signaling pathway: an overview

open access: yesRevista Brasileira de Hematologia e Hemoterapia, 2015
Myeloproliferative neoplasms are caused by a clonal proliferation of a hematopoietic progenitor. First described in 1951 as 'Myeloproliferative Diseases' and reevaluated by the World Health Organization classification system in 2011, myeloproliferative ...
Renata Mendes de Freitas   +1 more
doaj   +1 more source

Tyrosine kinase 2 - Surveillant of tumours and bona fide oncogene.

open access: yesCytokine, 2017
Tyrosine kinase 2 (TYK2) is a member of the Janus kinase (JAK) family, which transduces cytokine and growth factor signalling. Analysis of TYK2 loss-of-function revealed its important role in immunity to infection, (auto-) immunity and (auto ...
Nicole R. Leitner   +3 more
semanticscholar   +1 more source

Orchestration of autophagosome fusion by STRIPAK complex components in muscle tissue

open access: yesAutophagy Reports, 2023
Autophagy is a central process responsible for the disposal of normal as well as damaged cellular proteins and organelles. Proper regulation of multiple steps – including initiation and the fusion between autophagosomes and lysosomes – is essential for ...
Yungui Guo, Erika R. Geisbrecht
doaj   +1 more source

ABL fusion oncogene transformation and inhibitor sensitivity are mediated by the cellular regulator RIN1

open access: yesLeukemia, 2010
ABL gene translocations create constitutively active tyrosine kinases that are causative in chronic myeloid leukemia, acute lymphocytic leukemia and other hematopoietic malignancies.
M. Thai   +6 more
semanticscholar   +1 more source

Differential Subcellular Localization Regulates Oncogenic Signaling by ROS1 Kinase Fusion Proteins [PDF]

open access: yesCancer Research, 2019
Abstract Chromosomal rearrangements involving receptor tyrosine kinases (RTK) are a clinically relevant oncogenic mechanism in human cancers. These chimeric oncoproteins often contain the C-terminal kinase domain of the RTK joined in cis to various N-terminal, nonkinase fusion partners.
Dana S. Neel   +15 more
openaire   +5 more sources

Improvement of downstream processing of recombinant proteins by means of genetic engineering [PDF]

open access: yes, 1993
Flaschel E, Friehs K. Improvement of downstream processing of recombinant proteins by means of genetic engineering. Biotechnology Advances. 1993;11(1):31-77.The rapid advancement of genetic engineering has allowed to produce an impressive number of ...
Flaschel, Erwin, Friehs, Karl
core   +1 more source

Versatile toolbox for high throughput biochemical and functional studies with fluorescent fusion proteins [PDF]

open access: yes, 2012
Fluorescent fusion proteins are widely used to study protein localization and interaction dynamics in living cells. However, to fully characterize proteins and to understand their function it is crucial to determine biochemical characteristics such as ...
Sandra B. Hake (165089)   +15 more
core   +2 more sources

Menin-MLL inhibitors block oncogenic transformation by MLL-fusion proteins in a fusion partner-independent manner [PDF]

open access: yesLeukemia, 2015
Menin-MLL inhibitors block oncogenic transformation by MLL-fusion proteins in a fusion partner-independent ...
S, He   +14 more
openaire   +2 more sources

Home - About - Disclaimer - Privacy